Cvs Health (CVS) Non-Current Deferred Tax Liability (2009 - 2026)

Cvs Health (CVS) has 18 years of Non-Current Deferred Tax Liability data on file, last reported at $3.8 billion in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 2.92% year-over-year to $3.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (up 2.92% YoY) and the FY2025 annual result came in at $3.8 billion, down 66.42% from the prior year.
• Non-Current Deferred Tax Liability declined to $3.8 billion in Q1 2026, from $3.8 billion in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11.4 billion in Q4 2024 to a low of $3.5 billion in Q3 2022.
• A 5-year average of $4.6 billion and a median of $4.1 billion in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 164.74% — and 2025, when it sank 66.42%.
• Tracing CVS's Non-Current Deferred Tax Liability over 5 years: stood at $4.0 billion in 2022, then rose by 7.35% to $4.3 billion in 2023, then soared by 164.74% to $11.4 billion in 2024, then slumped by 66.42% to $3.8 billion in 2025, then fell by 1.59% to $3.8 billion in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $3.8 billion (Q1 2026), $3.8 billion (Q4 2025), and $3.5 billion (Q3 2025), per Business Quant data.